The Institute for Clinical and Economic Review. Anyone interested in health policy, or in assuring our healthcare system can one day provide effective cancer drugs at equitable prices, should know who they are and what they do, including recognizing when a critic completely misunderstands their use of QALY metrics. | Goldsmith & Florman, STAT News 2019


Popular Posts